We observed a significant increase in IL-10, TGF-β, and Arg1 (M2 markers) on day 3, and the levels reduced from day 7 until day 28 on the hematoma side, and no significant changes were detected on the other side (Figure 6B). This evidence concerns the gene IL10 and hematoma.